Serum brain-derived neurotrophic factor in euthymic bipolar patients on prophylactic lithium therapy

Neuropsychobiology

Volumn 62, Issue 4, 2010, Pages 229-234

  Suwalska, A ^a   Sobieska, M ^a   Rybakowski, J K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bipolar disorder; Brain derived neurotrophic factor; Lithium

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG RESISTANCE; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED;

EID: 77955532269     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319949     Document Type: Article

References (41)

1. Webster MJ, Herman MM, Kleinman JE, Shannon Weickert C: BDNF and trk B mR NA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns 2006; 6:941-951.
2. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, O wen M, Cr addo ck N, DePau lo J R, L a nder ES: Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002; 7: 579-593.
3. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL: The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
4. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH: Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 139: 51-53.
5. Rybakowski JK, Borkowska A, Skibinska M, Hauser J: Illness-specific association of Val-66Met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol Psychiatry 2006; 11:122-124.
6. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN: Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87:728-734.
7. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109:143-148.
8. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G: Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatr y 2005; 57: 1068-1072.
9. Gönül AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S: Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005; 255:381-386.
10. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54:70-75.
11. Neumeister A, Yuan P, Young TA, Bonne O, Luckenbaugh DA, Charney DS, Manji H: Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in un-medicated patients w it h rem itted depression and healthy subjects. Am J Psychiatry 2005; 162:805-807.
12. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA, Santin A, Kapczin-ski F: Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006; 398: 215-219.
13. Machado-Vieira R, Dietrich MO, Leke R, Ceresér VH, Zanatto V, Kapczinski F, Souza DO, Portela LV, Gentil V: Decreased plasma brain-derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 2007; 61:142-144.
14. Kauer-Sant'Anna M, Tramontina J, An-dreazza AC, Ceresér K, da Costa S, Santin A, Yatham LN, Kapczinski F: Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord 2007; 9(suppl 1):128-135.
15. Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F: Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett 2007; 420:45-48.
16. Monteleone P, Serritella C, Martiadis V, Maj M: Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord 2008; 10:95-100.
17. de Oliveira GS, Ceresér KM, Fernandes BS, Kauer-Sant'Anna M, Fries GR, Stertz L, Aguiar B, Pfaffenseller B, Kapczinski F: Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009; 43:1171-1174.
18. Fernandes BS, Gama CS, Kauer-Sant'Anna M, Lobato MI, Belmonte-de-Abreu P, Kapc-zinski F: Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res 2009; 43:1200-1204.
19. Tramontina JF, Andreazza AC, Kauer-Sant'Anna M, Stertz L, Goi J, Chiarani F, Kapczinski F: Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett 2009; 452:111-113.
20. Kauer-Sant'Anna M, Kapczinski F, Andreaz-za AC, Bond DJ, Lam RW, Young LT, Yatham LN: Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs late-stage bipolar disorder. Int J Neuro-psychopharmacol 2009; 12: 447-458.
21. Kapczinski F, Frey BN, Kauer-Sant'Anna M, Grassi-Oliveira R: Brain-derived neuro-trophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 2008; 8: 1101-1113.
22. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS: Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22:3251-3261.
23. Hashimoto K, Shimizu E, Iyo M: Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45:104-114.
24. Malberg JE, Eisch AJ, Nestler EJ, Duman RS: Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20:9104-9110.
25. Duman RS, Vaidya VA: Molecular and cellular actions of chronic electroconvulsive seizures. J ECT 1998; 14:181-193.
26. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G: The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003; 23: 7311-7316.
27. D'Sa C, Duman RS: Antidepressants and neuroplasticity. Bipolar Disord 2002; 4: 183-194.
28. Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé AA: Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsycho-pharmacol 2003; 6:225-231.
29. Fukumoto T, Morinobu S, Okamoto Y, Ka-gaya A, Yamawaki S: Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001; 158:100-106.
30. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, Gray NA, Zarate CA Jr, Charney DS: Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003; 53: 707-742.
31. Lee HY, Kim YK: Plasma brain-derived neu-rotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008; 57: 194-199.
32. Piccinni A , Marazziti D, Catena M, Domenici L, del Debbio A, Bianchi C, Mannari C, Martini C, da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovannini L, Massimetti G, Dell 'Osso L: Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 2008; 105: 279-283.
33. Huang TL, Lee CT, Liu YL: Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepres-sants. J Psychiatr Res 2008; 42:521-525.
34. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, Goka E: Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsy-chopharmacol Biol Psychiatry 2006; 30: 1256-1260.
35. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodzie-wicz A, Permoda A, Czerski PM, Hauser J: Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 2005; 38: 16 6-170.
36. Dmitrzak-Weglarz M, Rybakowski JK, Suw-alska A, Skibinska M, Leszczynska-Rodzie-wicz A, Szczepankiewicz A, Hauser J: Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharma-cogenomics 2008; 9: 1595-1603.
37. First M, Spitzer R, Gibbon M, Williams J: Structured Clinical Interview for DSM-IV Axis I Disorders. Research Version. New York, Biometrics Research, 1997.
38. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
39. Young R, Biggs J, Ziegler V, Meyer D: A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiat r y 1978; 133: 429-435.
40. Tramontina J, Frey BN, Andreazza AC, Zan-dona M, Santin A, Kapczinski F: Val66Met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatr y 2007; 12: 230-231.
41. Suwalska A, Łojko D, Janik J, Cyranik H, Ry-bakowski JK: Sustained attention deficits in euthymic bipolar patients. Int J Neuropsy-chopharmacol 2008; 11:228.